US, Europe and Asia Pacific Molecular Diagnostics Market: Market Analysis on Future Growth Prospects and Market Trends Embraced by Competitors, Regions Forecast to 2028 | Abbott Laboratories, Hologic, Inc., Grifols, SA

Molecular diagnostics is increasingly becoming an integral part of patient care. Cancer-specific mutation analysis and gene expression profiling can accurately identify inherited cancer syndromes and identify the best treatments for patients with these cancers. It has also helped to determine the biological parameters of malignant diseases, which can be used in personalized cancer therapy. Additionally, targeted treatment is becoming a common part of cancer therapy. Patients with mutations in the EGFR and BRAF genes receive targeted therapy using EGFR inhibitors. Tumors shed DNA, RNA, proteins, and tumor markers.

Key players operating in the market are focusing on receiving product approvals from regulatory authorities and this is expected to drive market growth during the forecast period.

Get a Research Sample PDF with Market Development Insights @ https://www.coherentmarketinsights.com/insight/request-sample/4919

For example, in January 2019, Qiagen, a global provider of molecular sampling and testing technologies, launched its QIAscreen HPV PCR test, for the detection of 15 recognized high-risk genotypes of human papillomavirus, which is a diagnostic test molecular in vitro with CE marking.

US, European and Asia Pacific Molecular Diagnostics Market: Impact of the Coronavirus (COVID-19) Pandemic

The COVID-19 outbreak was first reported on December 31, 2019 in Wuhan, China. According to the World Health Organization’s Weekly Epidemiological Update of Coronavirus (COVID-19), more than 260 million cases and 5.2 million deaths from coronavirus (COVID-19) were reported as of December 3, 2021 in all the world.

The COVID-19 pandemic and the lockdown in various countries around the world has had a negative impact on the financial health of companies in all sectors. Furthermore, the COVID-19 pandemic is expected to have a negative impact on the US, European and Asia Pacific molecular diagnostics market. However, the COVID-19 pandemic has increased the demand for PPE kits and gloves, leading to an increase in the production of PPE kits, helping the market grow.

As stated in the Medical Laboratory Observer, there is an increase in the demands for laboratory tests due to the emergence of the SARS-CoV-2 virus, even to keep up with the reported cases of COVID-19. When survey respondents were asked about the increase in testing demand, some respondents specified that their facilities have grown by as much as 25%.

Buy now to take advantage of the discount @ https://www.coherentmarketinsights.com/promo/buynow/4919

Note: The special discounted price only applies to direct purchase through the website. In case of customization, the discount would be subject to the scope and coverage of the report.

The most common molecular tests are based on viral RNA. These tests are known as nucleic acid amplification tests and begin with a sample from the nose or mouth of the infected person. Viral RNA is too small to be detected in minute amounts, so signal amplification is required. This method may take a day or two to complete. This technology has the potential to revolutionize the diagnosis of many diseases.

Key players operating in the market are focusing on adopting inorganic growth strategies such as mergers, launches, collaborations, and acquisitions to strengthen their position in the global market. For example, in February 2020, Qiagen, a global provider of molecular sampling and assay technologies, announced the launch and CE marking of the therascreen PIK3CA RGQ PCR Kit in Europe to aid in the recognition of PIK3CA-mutant breast cancer patients.

Key Insights from the US, European and Asia Pacific Molecular Diagnostics Market

  • The US, European and Asia Pacific molecular diagnostics market is expected to show a CAGR of 10.7% during the forecast period, due to increased product launches, agreements and regulatory approvals. For example, in September 2019, Amoy Diagnostics Co. Ltd., a pharmaceutical company engaged in the research, development, production, and sale of molecular diagnostic products, announced that the AmoyDx lung cancer PCR panel will be introduced as a first choice for patients who might benefit from targeted therapy in the Lung Cancer Genomic Screening for Individualized Medicine (LC-SCRUM) Project in Japan.
  • Among technology, the PCR-based segment is expected to account for the largest market share during the forecast period. The PCR-based segment is estimated to be worth US$7.147Mn in 2021, and is expected to post a CAGR of 10.7% and reach US$11Bn by 2028.
  • Major players operating in the US, European and Asia Pacific molecular diagnostics market include Abbott Laboratories, Hologic, Inc., Grifols, SA, Qiagen NV, F.Hoffmann-La Roche Ltd., Siemens Healthineers, Becton, Dickinson and Company, Beckmann Coulter, Inc., Bio-Rad Laboratories, and Thermo Fisher Scientific Inc..

Table of Contents

  1. Research objectives and assumptions
    • investigate targets
    • assumptions
    • abbreviations
  2. market scope
    • Report Description
      • Definition and scope of the market
    • Executive Summary
      • Market fragment, by product type
      • Market fragment, by technology
      • Market fragment, by application
      • Market fragment, by end users
      • Market fragment, by country
    • Coherent Map of Opportunities (COM)
  3. Analysis of market dynamics, regulations and trends
    • Market dynamics
      • drivers
      • restrictions
      • market opportunities
    • impact analysis
    • Approval and product releases
    • Fusions and acquisitions
    • key development
    • Regulatory Scenario
    • refund scenario
    • brand analysis
    • PEST analysis
    • Price analysis
    • Technological advance
  4. US, European and Asia Pacific Molecular Diagnostics Market: Impact of the Coronavirus (COVID-19) Pandemic
    • Overall impact of COVID-19
    • Epidemiology of COVID-19
  5. US, European and Asia Pacific Molecular Diagnostics Marketby product type, 2021 – 2028, (US$ Mn)
    • Introduction
      • Market share analysis, 2021 and 2028 (%)
      • Year-on-year growth analysis, 2018 – 2028
      • Segment trends
    • reagents
      • Introduction
      • Market Size and Forecast, and Growth YoY, 2017 – 2028, (US$ Mn)
    • Equipment and Instruments
      • Introduction
      • Market Size and Forecast, and Growth YoY, 2017 – 2028, (US$ Mn)
  6. US, Europe and Asia Pacific Molecular Diagnostics Market, by Technology, 2021 – 2028 (US$ Mn)
    • Introduction
      • Market share analysis, 2021 and 2028 (%)
      • Year-on-year growth analysis, 2018 – 2028
      • Segment trends
    • PCR-based
      • Introduction
      • Market Size and Forecast, and Growth YoY, 2017 – 2028, (US$ Mn)
        • Liquid biopsy tests
          • Introduction
          • Market Size and Forecast, and Growth YoY, 2017 – 2028, (US$ Mn)
        • tissue tests
          • Introduction
          • Market Size and Forecast, and Growth YoY, 2017 – 2028, (US$ Mn)
    • based on NGS
      • Introduction
      • Market Size and Forecast, and Growth YoY, 2017 – 2028, (US$ Mn)
        • Liquid biopsy tests
          • Introduction
          • Market Size and Forecast, and Growth YoY, 2017 – 2028, (US$ Mn)
        • tissue tests
          • Introduction
          • Market Size and Forecast, and Growth YoY, 2017 – 2028, (US$ Mn)
  7. US, Europe and Asia Pacific Molecular Diagnostics Market, by Application, 2021 – 2028 (US$ Mn)
    • Introduction
      • Market share analysis, 2021 and 2028 (%)
      • Year-on-year growth analysis, 2018 – 2028
      • Segment trends
    • Oncology
      • Introduction
      • Market Size and Forecast, and Growth YoY, 2017 – 2028, (US$ Mn)
    • genetic test
      • Introduction
      • Market Size and Forecast, and Growth YoY, 2017 – 2028, (US$ Mn)
    • Microbiology
      • Introduction
      • Market Size and Forecast, and Growth YoY, 2017 – 2028, (US$ Mn)
    • STDs
      • Introduction
      • Market Size and Forecast, and Growth YoY, 2017 – 2028, (US$ Mn)
    • Blood test
      • Introduction
      • Market Size and Forecast, and Growth YoY, 2017 – 2028, (US$ Mn)
    • Virology
      • Introduction
      • Market Size and Forecast, and Growth YoY, 2017 – 2028, (US$ Mn)
    • Tissue typing
      • Introduction
      • Market Size and Forecast, and Growth YoY, 2017 – 2028, (US$ Mn)
    • prenatal diagnosis
      • Introduction
      • Market Size and Forecast, and Growth YoY, 2017 – 2028, (US$ Mn)
    • Others
      • Introduction
      • Market Size and Forecast, and Growth YoY, 2017 – 2028, (US$ Mn)
  8. US, Europe and Asia Pacific Molecular Diagnostics Market, by End Users, 2021 – 2028, (US$ Mn)
    • Introduction
      • Market share analysis, 2021 and 2028 (%)
      • Year-on-year growth analysis, 2018 – 2028
      • Segment trends
    • hospitals
      • Introduction
      • Market Size and Forecast, and Growth YoY, 2017 – 2028, (US$ Mn)
    • clinics
      • Introduction
      • Market Size and Forecast, and Growth YoY, 2017 – 2028, (US$ Mn)
    • Ambulatory Surgery Centers
      • Introduction
      • Market Size and Forecast, and Growth YoY, 2017 – 2028, (US$ Mn)

About us:

Coherent Market Insights is a global market intelligence and consulting organization providing syndicated research reports, custom research reports and consulting services. We’re known for our hands-on insights and authentic reporting across multiple domains, including aerospace & defense, agriculture, food & beverage, automotive, chemicals & materials, and virtually every domain and exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed to playing a leadership role in delivering insights across multiple sectors post-COVID-19 and continuing to deliver measurable and sustainable results for our clients.

Contact Us:

Mr Shah
Coherent Market Insights Pvt Ltd,
533 Airport Boulevard, Suite 400, Burlingame, CA 94010, United States
Email: sales@coherentmarketinsights.com
Phone: USA: +1-206-701-6702
United Kingdom: +44-020-8133-4027
JAPAN: +81-50-5539-1737
INDIA: +91-848-285-0837

Leave a Reply

Your email address will not be published. Required fields are marked *